After infection, SARS-CoV-2 causes the host cell to produce new virus particles and suppresses host cell defence mechanisms. Virus protein nsP3 plays a central role in the latter process. Using structural analyses, researchers have now discovered that a decomposition product of the remdesivir binds to nsP3. This previously unknown effective mechanism may be important for the development of new drugs to combat RNA viruses.